Instil Bio, Inc. (TIL)
NCM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
March 2026
Instil Bio, Inc. — 8-K Filing
# 🧾 What This Document Is This is an **8-K filing**, which is like a company's "major news bulletin" for the stock market. Instil Bio is using it to report its financial results for the last quarter and full year of 2025, but more importantly, to announce a major strategic shift. They've stopped de
SEC filings
All filings →Insider trades
All insider trades →Instil Bio, Inc. has no reported insider trades in the last 90 days.